Literature DB >> 9455878

Depressed phagocytosis and oxidative burst in polymorphonuclear leukocytes from individuals with pulmonary tuberculosis with or without human immunodeficiency virus type 1 infection.

S Shalekoff1, C T Tiemessen, C M Gray, D J Martin.   

Abstract

Phagocytosis and oxidative burst in whole-blood granulocytes were assessed by flow cytometry with Phagotest and Bursttest kits, respectively. Seventy individuals were included in this study: 15 healthy, normal donors, 18 human immunodeficiency virus (HIV) type 1 (HIV-1)-seropositive patients, 19 patients with pulmonary tuberculosis (TB), and 18 patients co-infected with Mycobacterium tuberculosis and HIV-1 (TB-HIV). Granulocyte phagocytosis was assessed by incubating whole blood with fluorescence-labelled Escherichia coli and measuring the proportion of granulocytes with ingested bacteria and the capacity (fluorescence intensity) of each cell to phagocytose E. coli. The percentage of granulocytes converting nonfluorescent dihydrorhodamine to fluorescent rhodamine 123 on production of reactive oxygen intermediates (ROIs) and the mean channel shift were assessed as a measure of oxidative burst. No differences in the proportion of granulocytes that were capable of phagocytosing or producing ROIs in response to E. coli were observed between any of the study groups. Phagocytosis was significantly enhanced in granulocytes from HIV-1-infected individuals. On the other hand, granulocytes from individuals infected with M. tuberculosis alone or in combination with HIV-1 had a significantly reduced capacity to phagocytose E. coli and to produce ROIs in response to E. coli as an agonist. These results provide evidence that granulocytes from individuals with pulmonary TB with or without concomitant infection with HIV-1 have an impaired ability to phagocytose and to undergo oxidative burst, possibly contributing to the enhanced susceptibility to opportunistic infections in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9455878      PMCID: PMC121389          DOI: 10.1128/CDLI.5.1.41-44.1998

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  28 in total

1.  Evaluation of phagocyte functions, inflammatory lymphokine activities and in vitro antibody synthesis in patients with active and chronic pulmonary tuberculosis.

Authors:  S Antonaci; E Jirillo; A Polignano; M T Ventura; R Sabato; L Bonomo
Journal:  Cytobios       Date:  1991

2.  Impaired neutrophil function in patients with AIDS or AIDS-related complex: a comprehensive evaluation.

Authors:  M Ellis; S Gupta; S Galant; S Hakim; C VandeVen; C Toy; M S Cairo
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

3.  Impairment of neutrophil chemotactic and bactericidal function in children infected with human immunodeficiency virus type 1 and partial reversal after in vitro exposure to granulocyte-macrophage colony-stimulating factor.

Authors:  E Roilides; S Mertins; J Eddy; T J Walsh; P A Pizzo; M Rubin
Journal:  J Pediatr       Date:  1990-10       Impact factor: 4.406

4.  Immunoprofile studies in patients with pulmonary tuberculosis. III. Study of haemolytic complement in serum and phagocytic activity of blood neutrophils.

Authors:  M Rieger; L Trnka; J Skvor; P Mison
Journal:  Scand J Respir Dis       Date:  1979-08

5.  Mode of presentation and diagnosis of bacterial pneumonia in human immunodeficiency virus-infected patients.

Authors:  J L Magnenat; L P Nicod; R Auckenthaler; A F Junod
Journal:  Am Rev Respir Dis       Date:  1991-10

6.  Interleukin-8 enhances nonoxidative intracellular killing of Mycobacterium fortuitum by human granulocytes.

Authors:  P H Nibbering; O Pos; A Stevenhagen; R Van Furth
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  Decreased superoxide anion and hydrogen peroxide production by neutrophils and monocytes in human immunodeficiency virus-infected children and adults.

Authors:  T P Chen; R L Roberts; K G Wu; B J Ank; E R Stiehm
Journal:  Pediatr Res       Date:  1993-10       Impact factor: 3.756

8.  Depressed neutrophil superoxide production in human immunodeficiency virus infection.

Authors:  D L Pitrak; P M Bak; P DeMarais; R M Novak; B R Andersen
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

9.  Cohort study of human immunodeficiency virus infection in patients with tuberculosis in Nairobi, Kenya. Analysis of early (6-month) mortality.

Authors:  P Nunn; R Brindle; L Carpenter; J Odhiambo; K Wasunna; R Newnham; W Githui; S Gathua; M Omwega; K McAdam
Journal:  Am Rev Respir Dis       Date:  1992-10

10.  CD4+ lymphocyte count in African patients co-infected with HIV and tuberculosis.

Authors:  D J Martin; J G Sim; G J Sole; L Rymer; S Shalekoff; A B van Niekerk; P Becker; C N Weilbach; J Iwanik; K Keddy
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-04-01
View more
  18 in total

Review 1.  Antituberculosis treatment: increasing evidence for drug effects on innate cellular immunity.

Authors:  C T Tiemessen; S Shalekoff; S Meddows-Taylor; D J Martin
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

2.  Impaired interleukin-8-induced degranulation of polymorphonuclear neutrophils from human immunodeficiency virus type 1-infected individuals.

Authors:  S Meddows-Taylor; D J Martin; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Impaired phagocytosis among patients infected by the human immunodeficiency virus: implication for a role of highly active anti-retroviral therapy.

Authors:  C Michailidis; G Giannopoulos; V Vigklis; K Armenis; A Tsakris; P Gargalianos
Journal:  Clin Exp Immunol       Date:  2012-03       Impact factor: 4.330

Review 4.  Phagocytic activity in human immunodeficiency virus type 1 infection.

Authors:  Agostino Pugliese; Valerio Vidotto; Tiziana Beltramo; Donato Torre
Journal:  Clin Diagn Lab Immunol       Date:  2005-08

5.  Assessing immune function in adult bronchiectasis.

Authors:  P T King; P Hutchinson; P W Holmes; N J Freezer; V Bennett-Wood; R Robins-Browne; S R Holdsworth
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

6.  The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.

Authors:  Stipo Jurcevic; Charles Humfrey; Mohib Uddin; Steve Warrington; Bengt Larsson; Christina Keen
Journal:  Br J Clin Pharmacol       Date:  2015-10-02       Impact factor: 4.335

7.  Defective neutrophil degranulation induced by interleukin-8 and complement 5a and down-regulation of associated receptors in children vertically infected with human immunodeficiency virus type 1.

Authors:  S Meddows-Taylor; L Kuhn; T M Meyers; G Sherman; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

8.  Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency virus type 1 infection and pulmonary tuberculosis: implications for pathogenesis.

Authors:  S Shalekoff; S Pendle; D Johnson; D J Martin; C T Tiemessen
Journal:  J Clin Immunol       Date:  2001-11       Impact factor: 8.317

9.  Effects of anticoagulants and temperature on expression of activation markers CD11b and HLA-DR on human leukocytes.

Authors:  S Shalekoff; L Page-Shipp; C T Tiemessen
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

Review 10.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.